Suppr超能文献

[单导联VDD起搏的安全性与有效性]

[Safety and effectiveness of single-lead VDD pacing].

作者信息

Chabbar Boudet Maruan C, Lukic Antonella, Galache Osuna José G, De Juan Montiel Jesús, Cay Diarte Eduardo, Diarte de Miguel José A, Placer Peralta Luis J

机构信息

Unidad de Marcapasos, Servicio de Cardiología. Hospital Universitario Miguel Servet, Zaragoza, España.

出版信息

Rev Esp Cardiol. 2006 Sep;59(9):897-904. doi: 10.1157/13092797.

Abstract

INTRODUCTION AND OBJECTIVES

Single-lead VDD pacing provides the physiological benefits of atrioventricular synchrony with the convenience of a single-lead system. However, concern remains about the method's safety and effectiveness.

METHOD

In total, 700 patients with single-lead VDD pacemakers were evaluated retrospectively. The following parameters were recorded: age, sex, etiology, the symptoms and electrocardiographic diagnosis that justified pacemaker implantation, the venous access route used for implantation, atrial sensing at implantation, atrial undersensing at follow-up, the occurrence of supraventricular tachyarrhythmias, and final pacing mode.

RESULTS

Third-degree atrioventricular block was the main indication for pacemaker implantation (66.4%). The most commonly used venous access route was via the right cephalic vein (49.1%). At implantation, the mean atrial signal was 1.8 (4 1.15) mV. During follow-up, significant atrial undersensing occurred in 7.7% of patients; in 1.9%, it could not be corrected by device reprogramming. Uncontrollable supraventricular arrhythmias were observed in 6.4% of patients. Symptomatic sinus node disease was rare. By the end of follow-up, 91.4% of patients were still on VDD pacing, while, in 8.3%, the pacemaker had to be reprogrammed to the VVI mode. Only 0.3% required atrial lead implantation for DDD pacing. Left-side venous access during implantation was a independent predictora of atrial undersensing at follow-up. Low values of atrial detection at implant did not reach statistical signification although it showed a remarkable trend.

CONCLUSIONS

Single-lead VDD pacing seems to be safe and effective when appropriately indicated. Our findings are consistent with those of previously published studies.

摘要

引言与目的

单导联VDD起搏可提供房室同步的生理益处,且具有单导联系统的便利性。然而,该方法的安全性和有效性仍令人担忧。

方法

对700例植入单导联VDD起搏器的患者进行回顾性评估。记录以下参数:年龄、性别、病因、证明起搏器植入合理的症状和心电图诊断、植入所用的静脉通路、植入时的心房感知、随访时的心房感知不足、室上性快速心律失常的发生情况以及最终的起搏模式。

结果

三度房室传导阻滞是起搏器植入的主要指征(66.4%)。最常用的静脉通路是经右侧头静脉(49.1%)。植入时,平均心房信号为1.8(±1.15)mV。随访期间,7.7%的患者出现明显的心房感知不足;1.9%的患者经设备重新编程后仍无法纠正。6.4%的患者观察到无法控制的室上性心律失常。有症状的窦房结疾病很少见。随访结束时,91.4%的患者仍采用VDD起搏,8.3%的患者起搏器不得不重新编程为VVI模式。仅0.3%的患者需要植入心房导线进行DDD起搏。植入时左侧静脉通路是随访时心房感知不足的独立预测因素。植入时心房检测值较低虽有明显趋势,但未达到统计学意义。

结论

单导联VDD起搏在适应证合适时似乎是安全有效的。我们的研究结果与先前发表的研究一致。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验